Trial Profile
Tolerability, pharmacokinetics and effects on urinary glucose excretion of single ascending doses of TS 071 in male Japanese volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 May 2016
Price :
$35
*
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Taisho Pharmaceutical
- 18 Feb 2014 Results published in the Advances in Therapy.
- 04 Jul 2011 New trial record
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.